EPS Actual
—
Revenue
—
EPS Surprise
—
Status
Pending
Investor Toolbox
Read Transcript
Transcript not yet available.
View Infographic
Infographic not yet available.
GILD Coverage
Event
Gilead Sciences, Inc (GILD) FDA Approves Label Update for Kite’s Yescarta® for Relapsed/Refractory Primary Central Nervous System Lymphoma
Feb 6, 2026
Transcript
Gilead Sciences, Inc (GILD) Q2 2025 Earnings Call Transcript
Jan 22, 2026
Transcript
Gilead Sciences, Inc (GILD) Q3 2025 Earnings Call Transcript
Jan 22, 2026
News
Gilead Sciences (GILD) Earnings: 2Q23 Key Numbers
Aug 4, 2023
News
Gilead Sciences (GILD) Earnings: 1Q23 Key Numbers
Apr 28, 2023
News
Infographic: Highlights of Gilead Sciences (GILD) Q4 2022 earnings report
Feb 3, 2023
Transcript
Gilead Sciences Inc (GILD) Q2 2021 Earnings Call Transcript
Jul 29, 2021